REQUEST A DEMO
Total
USD $0.00
Search more companies

Lyumi OOO (Люми ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Lyumi OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Lyumi OOO (Люми ООО) is based in Russia, with the head office in Saint Petersburg. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on February 10, 2003. There was a net sales revenue drop of 16.02% reported in Lyumi OOO (Люми ООО)’s latest financial highlights for 2024. Its’ total assets recorded a growth of 80.09%. The net profit margin of Lyumi OOO (Люми ООО) decreased by 8.28% in 2024.

Headquarters
Reki Fontanki, 59, A, 7-N, Ofis №402
Saint Petersburg; Saint Petersburg; Postal Code: 191023

Contact Details: Purchase the Lyumi OOO (Люми ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Lyumi OOO (Люми ООО) report to view the information.
Financial Auditors:
Purchase the Lyumi OOO (Люми ООО) report to view the information.
Incorporation Date:
February 10, 2003
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Ekaterinburgskaya Farmacevticheskaya Fabrika OAO
47.2%
Company Performance
Financial values in the chart are available after Lyumi OOO (Люми ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-16.02%
Total operating revenue
-16.02%
Operating profit (EBIT)
-43.54%
Net Profit (Loss) for the Period
-67.76%
Total assets
80.09%
Total equity
53.53%
Operating Profit Margin (ROS)
-8.44%
Net Profit Margin
-8.28%
Return on Equity (ROE)
-19.4%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?